ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Clinical Cancer Advance of the Year Is CAR T Cells – Medscape

Continue reading

2018-01-30 Michael Zand NEWS

Blood Test to Determine Which Patients Will Respond to Immunotherapy – Technology Networks


Medscape

Clinical Cancer Advance of the Year Is CAR T Cells
Medscape
This product “can eradicate relapsed ALL in children. This represents one of the most remarkable advances in the treatment of childhood cancer in the last decade and could dramatically change treatment paradigms for this disease,” the report authors …
ASCO Names CAR T-Cell Therapy as Cancer Advance of the YearOncLive
CAR T-cell therapy named ASCO’s ‘Advance of the Year’Healio

all 4 news articles »

Continue reading

2018-01-30 Michael Zand NEWS

Blood Test to Determine Which Patients Will Respond to Immunotherapy – Technology Networks

Blood Test to Determine Which Patients Will Respond to Immunotherapy
Technology Networks
A test that measures the levels of two types of immune cell in the blood could identify which cancer patients are most likely to respond to immunotherapy. The test gives a measure of a patient’s immune system health by comparing the number of …

and more »

Continue reading

2018-01-30 Michael Zand NEWS

ASCO Names CAR T-Cell Therapy as Cancer Advance of the Year – OncLive


Technology Networks

Blood Test to Determine Which Patients Will Respond to Immunotherapy
Technology Networks
A test that measures the levels of two types of immune cell in the blood could identify which cancer patients are most likely to respond to immunotherapy. The test gives a measure of a patient’s immune system health by comparing the number of …

Continue reading

2018-01-30 Michael Zand NEWS

Blood test could indicate which patients will respond to … – The Institute of Cancer Research


OncLive

ASCO Names CAR T-Cell Therapy as Cancer Advance of the Year
OncLive
The FDA approved a pair of CAR T-cell therapies in 2017: tisagenlecleucel (Kymriah) for the treatment of children and young adults aged up to 25 with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL) and axicabtagene ciloleucel …
CAR T-cell therapy named ASCO’s ‘Advance of the Year’Healio

all 4 news articles »

Continue reading

2018-01-30 Michael Zand NEWS

Vaxil Completes Oversubscribed Financing to Advance Its Cancer Immunotherapy Research and Development – Marketwired (press release)

Vaxil Completes Oversubscribed Financing to Advance Its Cancer Immunotherapy Research and DevelopmentMarketwired (press release)NESS-ZIONA, ISRAEL–(Marketwired – January 30, 2018) – VAXIL BIO LTD. (TSX VENTURE: VXL), an innovative Israeli cancer immun… Continue reading

2018-01-30 Michael Zand NEWS

The messy biological basis of culture – Nature.com


The Institute of Cancer Research

Blood test could indicate which patients will respond to …
The Institute of Cancer Research
A test that measures the levels of two types of immune cell in the blood could identify which cancer patients are most likely to respond to immunotherapy. The test gives a measure of a patient’s immune system health by comparing the number of …

and more »

Continue reading

2018-01-30 Michael Zand NEWS

CRISPR gene-edited food in Europe? Questions remain on crop breeding regulations – Genetic Literacy Project

Genetic Literacy ProjectCRISPR gene-edited food in Europe? Questions remain on crop breeding regulationsGenetic Literacy ProjectOn January 18, 2018, European Union (EU) Advocate General Michal Bobek took a first stab at how new mutagenesis techniques m… Continue reading

2018-01-30 Michael Zand NEWS
  • 1
  • …
  • 599
  • 600
  • 601
  • 602
  • 603
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Nature.com

The messy biological basis of culture
Nature.com
Still, The Strange Order of Things addresses several important questions. One of the more compelling consequences of Damasio’s organic linkage of mental processes to the properties of biological hardware is that tinkering — such as the use of …